A game-changer for vascular access
Vascular access infections have drastic consequences on patients.
Infusion therapies often mean complex patient pathways.
Homecare solutions are on the rise but still need democratisation.
At SÆPTUM, our team and our tech answer these key challenges.
$10,658
Total costs associated with hæmodialysis access creation and maintenance in the first year.
Source: Sorber, R. et al. (2021).
+ 25%
In hæmodialysis access maintenance procedure costs to Medicare from 2010 to 2018.
Source: Sorber, R. et al. (2021).
18%
Of dialysis patients are required to be hospitalised for a vascular access-related complication.
Source: Manns B. et al. (2005).
Over 73%
Of patients may contract a healthcare-associated infection (HAI) due to the presence of a Peripheral venous-catheter. (PVC)
Source: Ríos R. et al. (2023)
Testimonies
SÆPTUM innovates by introducing groundbreaking port technology that facilitates extracorporeal treatments, including dialysis, with unparalleled safety and usability. As a care enabler, Saeptum will transform the landscape of patient-centered innovation, seamlessly integrating advanced technology to optimize clinician workflows and improve patient outcomes.
Pr. Bernard CANAUD - Nephrologist
Testimonies
SÆPTUM is a disruptive company revolutionizing the MedTech sector with innovative, cutting-edge solutions. Thanks to a bold approach and its state-of-the-art technology, SÆPTUM redefines the rules of healthcare solutions by anticipating tomorrow's needs. Its unique vision makes it a key player, ready to transform today's healthcare challenges into tomorrow's opportunities.
Dr. Hafedh FESSI - Nephrologist & renal therapies expert
